Awake craniotomy with dexmedetomidine in pediatric patients

Journal of Neurosurgical Anesthesiology

Volumn 15, Issue 3, 2003, Pages 263-266

  Ard, John ^a   Doyle, Werner ^b   Bekker, Alex ^a,c  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^c NEW YORK UNIVERSITY   (United States)

Author keywords

Awake; Craniotomy; Dexmedetomidine; Temporal lobe epilepsy

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; DEXMEDETOMIDINE;

ANALGESIA; ANESTHESIOLOGICAL TECHNIQUES; ARTICLE; BRAIN CORTEX; BRAIN MAPPING; CASE REPORT; CHILD; CRANIOTOMY; FEMALE; GENERAL ANESTHESIA; HUMAN; LARYNGEAL MASK; MALE; NEUROPSYCHOLOGICAL TEST; PEDIATRIC SURGERY; PRIORITY JOURNAL; SEDATION; SLEEP WAKING CYCLE; SPEECH; WAKEFULNESS;

CHILD; CRANIOTOMY; DEXMEDETOMIDINE; EPILEPSY; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; MALE; WAKEFULNESS;

EID: 0037707400     PISSN: 08984921     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008506-200307000-00015     Document Type: Article

References (15)

1. Gignac E, Manninen PH, Gelb AW. Comparison of fentanyl, sufentanil and alfentanil during awake craniotomy for epilepsy. Can J Anaesth. 1993;40:421-4.
2. Herrick IA, Craen RA, Gelb AW, et al. Propofol sedation during awake craniotomy for seizures: patient controlled administration versus neurolept analgesia. Anesth Analg. 1997;84:285-91.
3. Berkenstadt H, Perel A, Hadani M, et al. Monitored anesthesia care using remifentanil and propofol for awake craniotomy. J Neurosurg Anesthesiol. 2001;13:246-50.
4. Archer DP, McKenna JM, Morin L, et al. Conscious-sedation analgesia during craniotomy for intractable epilepsy: a review of 354 consecutive cases. Can J Anaesth. 1988;35:338-44.
5. Danks RA, Rogers M, Aglio LS, et al. Patient tolerance of craniotomy performed with the patient under local anesthesia and monitored conscious sedation. Neurosurgery. 1998;42:28-36.
6. Tobias JD, Jimenez D. Anaesthetic management during awake craniotomy in a 12-year-old boy. Paediatr Anaesth. 1997;7:341-4.
7. Welling E, Donegan J. Neuroleptanalgesia using alfentanil for awake craniotomy. Anesth Analg 1989;68:57-60.
8. Belleville JP, Ward DS, Bloor BC, et al. Effects of intravenous dexmedetomidine in humans: I. Sedation, ventilation, and metabolic rate. Anesthesiology, 1992;77:1125-33.
9. Hall EJ, Uhrich TD, Barney JA, et al. Sedative, amnestic, and analgesic properties of small-dose dexmedetomidine infusions. Anesth Analg. 2000;90:699-705.
10. Bekker A, Kaufman B, Samir H, et al. The use of Dexmedetomidine infusion for awake craniotomy. Anesth Analg. 2001;92:1251-3.
11. Silbergeld DL, Mueller WM, Colley PS, et al, Use of propofol (Diprivan) for awake craniotomies: technical note. Surg Neurol, 1992;38:271-2.
12. Aho M, Lehtinen AM, Erkola O, et al, The effect of intravenously administered dexmedetomidine on perioperative hemodynamics and isoflurane requirements in patients undergoing abdominal hysterectomy. Anesthesiology. 1991;74:997-1002.
13. Aho MS, Erkola OA, Scheinen H, et al. Effect of intravenously administered dexmedetomidine on pain after laparoscopic tubal ligation. Anesth Analg. 1991;73:112-8.
14. Ebert TJ, Hall JE, Barney JA, et al. The effects of increasing plasma concentrations of dexmedetomidine in humans, Anesthesiology, 2000;93:382-94.
15. Bustillo M, Lazar R, Finck A, et al. Dexmedetomidine may impair cognitive testing during endovascular embolization of cerebral arteriovenous malformations: a retrospective case reports series. J Neurosurg Anesthesiol. 2002;14:209-12.